Covered recipient · General Payments record
SON D NGUYEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$213.15
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $213.15 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $49.75 | 2 |
| Exact Sciences Corporation | $49.22 | 2 |
| Acerta Pharma LLC | $36.73 | 2 |
| Merck Sharp & Dohme Corporation | $20.21 | 1 |
| Lilly USA, LLC | $15.43 | 1 |
| Inari Medical, Inc. | $14.07 | 1 |
| ABBVIE INC. | $13.87 | 1 |
| GlaxoSmithKline, LLC. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $213.15 | 11 |
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.87 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105121301 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.10 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105869483 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.63 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104338362 | CMS |
| Exact Sciences Corporation | $25.41 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114441306 | CMS |
| Exact Sciences Corporation | $23.81 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114441310 | CMS |
| GlaxoSmithKline, LLC. | $13.87 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116236984 | CMS |
| Inari Medical, Inc. | $14.07 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140150010 | CMS |
| Lilly USA, LLC | $15.43 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135408473 | CMS |
| Merck Sharp & Dohme LLC | $20.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141750413 | CMS |
| Novo Nordisk Inc | $22.59 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096805796 | CMS |
| Novo Nordisk Inc | $27.16 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097032406 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.